The effect of xanthinol nicotinate on the serum lipids and lipoproteins of patients with primary hyperlipoproteinemia Type IIb and IV
Haacke, H.; Parwaresch, M.R.; Mäder, C.
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 82 Pt 1: 829-832
1976
ISSN/ISBN: 0070-4067 PMID: 1029294 Document Number: 98092
Document emailed within 1 workday
Related Documents
Hutt, V.; Wechsler, J.G.; Klör, H.U.; Ditschuneit, H. 1983: Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V Arzneimittel-Forschung 33(5): 776-779Shinomiya, M.; Ishikawa, Y.; Shirai, K.; Saito, Y.; Yoshida, S. 1987: Effect of pirozadil on lipids, lipoproteins and apolipoproteins in Japanese with type IIa hyperlipoproteinemia Arzneimittel-Forschung 37(9): 1069-1071
von Schrader, H.W.; Buscher, G.; Dierdorf, D.; Freytag, A.; Mügge, H.; Wolf, D. 1985: Bioavailability and tolerance of xanthinol nicotinate depot preparations. Comparison of a conventional 500 mg xanthinol nicotinate depot tablet with new 500 mg and 1 g depot tablets Arzneimittel-Forschung 35(9): 1468-1472
Mughal, M.A.; Memon, M.Y.; Zardari, M.K.; Tanwani, R.K.; Ali, M. 2000: Effect of acarbose on glycemic control, serum lipids and lipoproteins in type 2 diabetes Jpma. Journal of the Pakistan Medical Association 50(5): 152-156
Noseda, G.; Suvà, F.; Fragiacomo, C. 1985: Modification of serum lipids, lipoproteins and apoproteins Ai and B in patients with hyperlipidemia Type IIa and IIb using polyenylphosphatidylcholine Schweizerische Medizinische Wochenschrift 115(30): 1064-1070
Zák, A.; Zeman, M.; Tvrzická, E. 1998: Fatty acid composition of plasma phosphatidylcholine and levels of lipids and lipoproteins in hyperlipoproteinemia. II. Relation with B lipoproteins Casopis Lekaru Ceskych 137(13): 400-403
Sznajderman, M.; Niegowska, J.; Sawicki, M.; Sznajderman, M. 1987: Delayed-action nifedipine in the treatment of primary hypertension: its effect on blood pressure and serum lipids and lipoproteins Kardiologia Polska 30 Suppl: 29-37
Brenner, G. 1983: Effect of xanthinol nicotinate on brain metabolism in rats Arzneimittel-Forschung 33(5): 698-701
Sivkov, I.I.; Kukes, V.G.; Borisov, V.G.; Rudakov, M.A.; Blistanova, L.S. 1977: Use of xanthinol nicotinate in patients with chronic ischemic heart disease Terapevticheskii Arkhiv 49(1): 30-33
Stepaniuk, G.I.; Ornostaĭ, V.V.; Kozlov, V.G. 1992: Comparative evaluation of the wound-healing effect of benzofuracaine, etaden, and xanthinol nicotinate in an experiment Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 3: 16-18
Renaud, R.; Bock, A.; Chambron, J.; Rosenthal, C.; Raffi, F.; Bidet, R.; Steinling, M. 1976: Simultaneous study of the placental, myometrial and cervical circulations (indium 113 and anemometric thermometry). 2. Effect of xanthinol nicotinate Journal de Gynecologie Obstetrique et Biologie de la Reproduction 5(4): 513-517
Kwiterovich, P.O.; Bachorik, P.S.; Franklin, F.A.; Margolis, S.; Georgopoulos, L.; Teng, B.; Sniderman, A.D. 1985: Effect of dietary treatment on the plasma levels of lipids, lipoprotein cholesterol and LDL B protein in children with type Ii hyperlipoproteinemia Progress in Clinical and Biological Research 188: 123-137
Zák, A.; Zeman, M.; Tvrzická, E. 1998: Fatty acid composition of phosphatidylcholine and levels of lipids and lipoproteins in hyperlipoproteinemia. I. Relation to HDL lipoprotein Casopis Lekaru Ceskych 137(12): 368-371
Kłosiewicz-Latoszek, L.; Nowicka, G.; Szostak, W.B. 1993: Effect of combined treatment with lovastatin and colestipol on serum lipids and lipoproteins Wiadomosci Lekarskie 46(15-16): 581-585
Cisternas, J.R.; Milstein-Kuschnaroff, T. 1987: The effect of human leptospirosis on the composition and concentration of serum lipids and lipoproteins Brazilian Journal of Medical and Biological Research 20(2): 149-159
Arora, S.; Arora, R.C.; Garg, R.K.; Agarwal, N.; Nautiyal, A. 1988: Effect of administration and withdrawal of oral contraceptive pills on serum lipids and lipoproteins Indian Journal of Physiology and Pharmacology 32(1): 67-71
Heldenberg, D.; Harel, S.; Holtzman, M.; Levtow, O.; Tamir, I. 1983: The effect of chronic anticonvulsant therapy on serum lipids and lipoproteins in epileptic children Neurology 33(4): 510-513
Parsons, H.G.; Thirsk, J.E.; Frohlich, J.; Dias, V.; Minuk, G.Y. 1989: Effect of cyclosporin A on serum lipids in primary biliary cirrhosis patients Clinical and Investigative Medicine 12(6): 386-391
Seyoum, B.; Abdulkadir, J.; Berhanu, P.; Feleke, Y.; Mengistu, Z.; Worku, Y.; Ayana, G. 2003: Analysis of serum lipids and lipoproteins in Ethiopian diabetic patients Ethiopian Medical Journal 41(1): 1-8
Romics, L.; Karádi, I.; Csanády, M.; Gógl, A.; Jánosi, A.; Ofner, P.; Tarján, J.; Varga, L.; Wórum, F.; Zeltner, G. 1994: Effect of lovastatin on serum lipids and lipoproteins. Hungarian multicenter, open-label study Orvosi Hetilap 135(40): 2187-2191